HHMI
IR icon

Howard Hughes Medical Institute’s Ingersoll Rand IR Stock Holding History

Howard Hughes Medical Institute’s Portfolio IR Stock Details IR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-78
Closed -$6.18K – 263
2025
Q4 		$6.18K Hold
78
– – ﹤0.01% 295
2025
Q3 		$6.44K Sell
78
-9
-10% -$738 ﹤0.01% 290
2025
Q2 		$7.24K Buy
+87
New +$6.86K ﹤0.01% 261

Other funds holding IR

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Howard Hughes Medical Institute's IR Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Ingersoll Rand (IR) in Q1 2026, closing a stake of 78 shares — an estimated $6.18K sold.

Howard Hughes Medical Institute first reported a position in IR in Q2 2025 and held it in 3 quarters. The position peaked at $7.24K in Q2 2025. 898 funds tracked by Wall St. Rank hold IR as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Ingersoll Rand position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 78 Ingersoll Rand shares in Q1 2026, an estimated $6.18K.
  • Howard Hughes Medical Institute first reported a position in Ingersoll Rand in Q2 2025 and held it in 3 quarters.
  • Howard Hughes Medical Institute's Ingersoll Rand position peaked at $7.24K in Q2 2025.
  • 898 funds tracked by Wall St. Rank held Ingersoll Rand as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.